Skip to main content

Table 2 Percutaneous coronary intervention procedure and angiographic findings

From: Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

Variables Group A Control C1 p Value Control C2 p Value p Value
   (A vs C1)   (C1vs C2) (A vs C2)
Lesion characteristics
 Multivessel PCI 13 (43.3%) 9 (30.0%) 0.421 25 (32.1%) 1.000 0.381
 Target vessel
  Left main disease 0 (0.0%) 1 (3.3%) 1.000 5 (6.4%) 0.875 0.378
  Left anterior descending artery 18 (60.0%) 19 (63.3%) 1.000 47 (60.3%) 0.941 1.000
  Left circumflex artery 11 (36.7%) 11 (36.7%) 1.000 31 (49.7%) 0.941 0.941
  Right coronary artery 11 (36.7%) 11 (36.7%) 1.000 20 (25.6%) 0.370 0.370
 IVUS guidance 9 (31.0%) 4 (13.3%) 0.184 21 (26.9%) 0.213 0.858
 Type B2/C lesion 36 (73.5%) 35 (79.5%) 0.657 90 (81.8%) 0.922 0.323
 Restenotic lesion 2 (2.3%) 1 (4.3%) 1.000 0 (0.0%) 0.634 0.161
 Angiographic thrombus 13 (43.3%) 11 (36.7%) 0.792 30 (38.5%) 1.000 0.807
Procedure characteristics
 Stents per target lesion (n) 1.20 ± 0.41 1.09 ± 0.29 0.124 1.05 ± 0.23 0.460 0.009
 Stent type
  Drug eluting balloon 1 0   0   
  Bare metal stent 0 1   0   
  Drug-eluting stent 53 47   117   
 Stent size 2.70 ± 0.47 2.79 ± 0.46 0.651 2.84 ± 0.45 0.409 0.737
 Stent length 23.7 ± 8.7 21.8 ± 5.5 0.548 23.0 ± 8.7 0.613 0.838
 Duration of loading time to the procedure 34.0 ± 18.6 29.9 ± 18.3 0.480 29.4 ± 16.1 0.917 0.270
 Emergency PCI 1 1   0   
  1. PCI percutaneous coronary intervention, IVUS intravascular ultrasound